Appendix 4D and Interim Financial Report
Filed with ASX · · 28 pages · English
Earlier from AnteoTech
- Response to ASX Query
- AnteoTech receives $3.2m R&D Tax Incentive
- Managing Director AGM Presentation
- European RAT Clinical Trial Halted to Refocus Initiatives
- FY22 Results Announcement
Later from AnteoTech
- AnteoTech signs MOU with Trinseo
- AnteoTech signs Non-Binding MOU with Wyon
- S&P DJI Announces March 2023 Quarterly Rebalance
- Quarterly Update and Appendix 4C
- Response to ASX Price Query
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech